Brief: DBP Q1 Oper Loss Widens To SEK 4.3 Mln
07/05/2020 10:15
May 7 (Reuters) - Double Bond Pharmaceutical International
AB DBPHAb.TE :
* Q1 TOTAL REVENUE SEK 0.7 MLN VS SEK 0.4 MLN YR AGO
* Q1 OPER LOSS SEK 4.3 MLN VS LOSS SEK 2.0 MLN YR AGO
* THE GROUP WAS NOT BADLY AFFECTED BY THE COVID-19 OUTBREAK
Source text for Eikon: urn:newsml:reuters.com:*:nWkr3P7v3V
Further company coverage: DBPHAb.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University